There is also concern about the proposal for improving PVA through research service. Last year, researchers (Bae Seung -jin, Ewha Womans University, etc.), who studied PVA's performance evaluation and improvement plan, ordered the screening management of drugs with high financial impacts. As a result, the selection criteria for the usage type 'Ka' were proposed to expand by adding 5 billion won and a 10% increase in the existing claims. Drugs with low financial impacts, such as a plan to raise the exclusion of negotiations from 2 billion won to 3 billion to 5 billion won, are required to ease management. The proposal for improvement will be discussed in May and institutionalized from January next year. In summary, th